Friday, November 20, 2026

ASA and CRC

Q: Aspirin may reduce the mortality rate in colorectal cancer (CRC).

A) True
B) False


Answer: A

Although evidence is weak, it doesn't change clinical practice and may be of only academic value; aspirin (ASA) has been shown to inhibit colorectal carcinogenesis and may influence metastases and related mortality in CRC.  Similar weak evidence extends to NSAIDs.

This risk reduction is long-term (in years) but likely reduces colorectal cancer mortality.


#oncology


References:

1. Ma S, Han T, Sun C, Cheng C, Zhang H, Qu G, Bhan C, Yang H, Guo Z, Yan Y, Cao C, Ji Z, Zhou Q. Does aspirin reduce the incidence, recurrence, and mortality of colorectal cancer? A meta-analysis of randomized clinical trials. Int J Colorectal Dis. 2021 Aug;36(8):1653-1666. doi: 10.1007/s00384-021-03889-8. Epub 2021 Feb 16. PMID: 33594505.

2. Sung JJY, Ho JMW, Chan FCH, Tsoi KKF. Low-dose aspirin can reduce colorectal cancer mortality after surgery: A 10-year follow-up of 13 528 colorectal cancer patients. J Gastroenterol Hepatol. 2019 Jun;34(6):1027-1034. doi: 10.1111/jgh.14562. Epub 2019 Jan 14. PMID: 30515899.

3. Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010; 376:1741.

Thursday, November 19, 2026

vitamin B deficiency induced by metformin

Q: Metformin may decrease the level of which vitamin B? - select one

A) B1 (Thiamin)
B) B3 (Niacin)
C) B6 (Pyridoxine)
D) B9 (Folate)
E) B12 (Cobalamin)


Answer: E

Metformin tends to impair intestinal absorption of vitamin B12 and may cause megaloblastic anemia, leading to peripheral neuropathy. It is a dose-dependent effect. This occurs due to poor B12 absorption in the ileum. This may get worse with co-existing poor dietary intake, absorption issues, and long-term ( above 5 years) metformin use.

Co-administering oral calcium carbonate at 1.2 g daily or a daily multivitamin may prevent this complication.


#pharmacology
#vitamins
#GI
#hematology
#neurology


References:

1. Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab 2016; 101:1754.

2. Bell DS. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J 2010; 103:265.

3. Bauman WA, Shaw S, Jayatilleke E, et al. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care 2000; 23:1227.

Wednesday, November 18, 2026

Steroids in heart transplant

Q: Glucocorticoids are usually given for immunosuppression in heart transplant? - select one

A) Upon start of cardiopulmonary bypass of the transplant surgery
B) Upon separation from cardiopulmonary bypass after the transplant surgery


Answer: B

Glucocorticoids play an integral role in all solid organ transplantations by interrupting multiple steps in immune activation, including antigen presentation, cytokine production, and lymphocyte proliferation. They are highly effective for preventing and treating acute rejection.

Glucocorticoids are given as an initial dose of 500 mg upon separation from cardiopulmonary bypass. They are continued at 125 mg every eight hours during the first 24 hours after transplantation. Subsequently, oral prednisone is started at a dose of 1 to 1.5 mg/kg/day and subsequently tapered over a year.


#transplantation


Further readings:

1. Nikolova AP, Bellumkonda L, Bhardwaj A, Fida N, Holzhauser L, Umapathi P, De Marco T, Contreras J. Practical Guide on the Use of Induction Immunosuppression in Heart Transplantation. Circ Heart Fail. 2025 Oct;18(10):e012382. doi: 10.1161/CIRCHEARTFAILURE.124.012382. Epub 2025 May 15. PMID: 40371476.

2. Minato C, Nasri A, Noly PE, Boulet J, Parent MC, Fortier A, de Denus S, Tremblsay-Gravel M, Giraldeau G, Lamarche Y, Ducharme A. Rapid Corticosteroid Withdrawal After Cardiac Transplantation Improves Outcomes. Clin Transplant. 2025 Dec;39(12):e70420. doi: 10.1111/ctr.70420. PMID: 41405005; PMCID: PMC12710205.

Tuesday, November 17, 2026

Aerococcus

Q; 52 year old male with previous urological surgeries is admitted to the ICU with severe sepsis. Blood cultures grew Aerococcus. Which of the following Antibiotics is preferred as an initial choice? - Select one

A) Amoxicillin 
B) Fluoroquinolone 
C) Trimethoprim-sulfamethoxazole 


Answer: A

Aerococcus is a Gram-positive coccus. The reason this question is asked is that, in recent years, its epidemiology has been rising. Interestingly, they respond well to old-fashioned amoxicillin but may have high resistance to fluoroquinolones and trimethoprim-sulfamethoxazole. Further in course, antibiotics should be given depending on susceptibility.

It's called Aerococcus because they were initially identified from air and dust samples.

In the lab, they can deceive clinicians because they resemble alpha-hemolytic Streptococcus on blood agar plates and may require specific confirmatory tests.


#ID


References:


1. Rasmussen M. Aerococci and aerococcal infections. J Infect. 2013 Jun;66(6):467-74. doi: 10.1016/j.jinf.2012.12.006. Epub 2012 Dec 28. PMID: 23277106.

2. Rasmussen M. Aerococcus: an increasingly acknowledged human pathogen. Clin Microbiol Infect 2016; 22:22.

3. Ahmadzada A, Fuchs F, Hamprecht A. Susceptibility of Aerococcus urinae and Aerococcus sanguinicola to Standard Antibiotics and to Nitroxoline. Microbiol Spectr 2023; 11:e0276322.

Monday, November 16, 2026

major clinical determinants - takotsubo cardiomyopathy.

Q: A 34 year old female is admitted to the ICU with acute chest pain, syncope, and shortness of breath after hearing the news of her son's car accident, and is diagnosed with stress cardiomyopathy (takotsubo cardiomyopathy) with cardiogenic shock. What is the main determinant a clinician needs to make to carve the management plan?

Answer: 

The management of stress cardiomyopathy highly depends on whether there is:
  • LVOT obstruction is present, or
  • no LVOT obstruction is present
Volume depletion and vasodilator therapy need to be avoided in patients with LVOT obstruction, in contrast to the standard of other cardiogenic shock syndromes. Euvolumeia is preferred with a fine line to avoid pulmonary edema. Patients who develop LVOT obstruction are at higher risk of developing shock. LVOT obstruction can be accompanied by systolic anterior motion (SAM) of the mitral valve and mitral regurgitation, similar to that seen in hypertrophic cardiomyopathy. Inotropic agents should be avoided if SAM or severe LVOT obstruction is present.

A quick clinical bedside tip in management of stress cardiomyopathy with LVOT obstruction when shock is profound is to increase preload with leg elevation and fluid resuscitation, again keeping a close eye on pulmonary edema. Phenylephrine, as a pure alpha-adrenergic agonist (or vasopressin), increases afterload and may help decrease the gradient, thereby improving hemodynamics, though the risk of coronary spasm is inherent. A beta blocker should be added judiciously to reduce inotropy. In such a shock situation, IABP needs to be inserted despite some risk of afterload reduction from IABP.

For reasons not fully understood, younger patients are more prone to develop shock, probably a manifestation of high catecholamine effect.

#hemodynamics


References:

1. Vila-Sanjuán S, Nuñez-Gil IJ, Vedia O, Corbi-Pascual M, Salamanca J, Martinez-Selles M, Blanco E, Almendro-Delia M, Pérez-Castellanos A, Martin-Garcia AC, Tomasino M, Vazirani R, Fernández-Cordón C, Duran Cambra A, Becerra-Muñoz VM, Guillén M, Reyes JA, Uribarri A. Left ventricular outflow tract obstruction in Takotsubo syndrome with cardiogenic shock: prognosis and treatment. Heart. 2024 Nov 19;110(23):1381-1388. doi: 10.1136/heartjnl-2024-324205. PMID: 39209437.

2. Ozaki K, Okubo T, Tanaka K, Hosaka Y, Tsuchida K, Takahashi K, Oda H, Minamino T. Manifestation of Latent Left Ventricular Outflow Tract Obstruction in the Acute Phase of Takotsubo Cardiomyopathy. Intern Med. 2016;55(23):3413-3420. doi: 10.2169/internalmedicine.55.7119. Epub 2016 Dec 1. PMID: 27904102; PMCID: PMC5216136.

3. Kawaji T, Shiomi H, Morimoto T, Tazaki J, Imai M, Saito N, Makiyama T, Shizuta S, Ono K, Kimura T. Clinical impact of left ventricular outflow tract obstruction in takotsubo cardiomyopathy. Circ J. 2015;79(4):839-46. doi: 10.1253/circj.CJ-14-1148. Epub 2015 Jan 28. PMID: 25739572.

Sunday, November 15, 2026

Categories of Plasma Exchange

Q: 'Plasma exchange' in Lambert-Eaton myasthenic syndrome is considered a Category I indication.

A) Yes
B) False


Answer: B

The objective of this question is to familiarize students with the academic basis of therapeutic categories of Plasma Exchange (PE), a broadly described term for different categories of Apheresis. The American Society for Apheresis (ASFA) systematically describes these categories to prevent abuse of this high-risk procedure.

Category I – first-line therapy, either as primary stand-alone treatment or in conjunction with other modes of treatment. Classic examples 
  • immune TTP
  • acute inflammatory demyelinating polyradiculoneuropathy
  • sickle cell disease with certain complications such as stroke

Category II – apheresis is accepted "as second-line therapy," either as a stand-alone treatment or in conjunction with other treatments. Examples are
  • life-threatening hemolytic anemia for cold agglutinin disease 
  • Lambert-Eaton myasthenic syndrome (see above question)

Category III – optimum role of apheresis therapy is not established.
  • hypertriglyceridemic pancreatitis 
  • extracorporeal photopheresis for nephrogenic systemic fibrosis

Category IV – evidence suggests apheresis may be ineffective or harmful. AFSA recommends approval from either hospital's IRB or equivalent committee. Examples:
  • certain drug-induced thrombotic microangiopathies


*AFSA documents most of the PE-required disease processes under each category for clinicians to refer to.


#procedures
#hematology



References:

1. Connelly-Smith L, Alquist CR, Aqui NA, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue. J Clin Apher 2023; 38:77.

2. Kaplan AA. Therapeutic plasma exchange: core curriculum 2008. Am J Kidney Dis 2008; 52:1180.

Thursday, November 12, 2026

on endocarditis

Q: A 58-year-old male with End-Stage Renal Disease (ESRD) is admitted to the ICU with septic shock and is found to have Candida endocarditis. Which of the following is more prone to cause peripheral embolization? - select one

A) Bacterial endocarditis
B) Candida endocarditis 


Answer: A

Candida endocarditis differs from bacterial endocarditis in that it causes larger vegetations and therefore has a greater tendency to cause peripheral embolization. That explains the standard of performing an ophthalmic exam in Candida endocarditis to rule out endophthalmitis. This also explains that, in most patients, blood cultures remained positive with persistent candidemia despite treatment.

Risk factors are prosthetic heart valves, intravenous drug abuse, indwelling catheters, and prolonged candidemia.


##ID
#cardiology


References:

1. Jamil Y, Akinleye A, Mirzaei M, Lempel M, Farhat K, Pan S. Candida endocarditis: Update on management considerations. World J Cardiol. 2023 Oct 26;15(10):469-478. doi: 10.4330/wjc.v15.i10.469. PMID: 37900901; PMCID: PMC10600790.

2. Lefort A, Chartier L, Sendid B, Wolff M, Mainardi JL, Podglajen I, Desnos-Ollivier M, Fontanet A, Bretagne S, Lortholary O; French Mycosis Study Group. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect. 2012 Apr;18(4):E99-E109. doi: 10.1111/j.1469-0691.2012.03764.x. Epub 2012 Feb 13. PMID: 22329526.

3. Meyahnwi D, Siraw B, Issaka Y, Tafesse Y, Zinyandu T, Miftari R, Ahmed A. Candida endocarditis in the United States: contemporary clinical predictors of mortality from a nationwide analysis (2016-2022). Infection. 2026 Jun;54(3):1359-1368. doi: 10.1007/s15010-026-02757-3. Epub 2026 Mar 5. PMID: 41784858.

Wednesday, November 11, 2026

RAPID

Q: The RAPID score is developed for risk stratification in? - select one

A) pericardial effusion
B) pleural effusion 


Answer: B

Generally, the long-term survival of patients with parapneumonic effusion and empyema is good if therapy is prompt.

The RAPID score is developed for risk stratification in pleural infections. RAPID stands for:
  • Renal function (based on BUN)
  • Age
  • Purulence (yes or no)
  • Infection source (community vs hospital-acquired)
  • Dietary factors (based on serum albumin)

0 to 2 points: Low risk; 1.5% 3-month mortality
3 to 4 points: Medium risk; 17.8% 3-month mortality
5 to 7 points: High risk; 47.8% 3-month mortality


The score can be found on any internet search engine


References:

1. White HD, Henry C, Stock EM, et al. Predicting Long-Term Outcomes in Pleural Infections. RAPID Score for Risk Stratification. Ann Am Thorac Soc 2015; 12:1310.

2. Rahman NM, Kahan BC, Miller RF, et al. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest 2014; 145:848.

Sunday, November 8, 2026

urine alkalinization

Q: Acetazolamide is a good choice for urinary alkalinization when sodium bicarbonate is contraindicated.

A) True
B) False


Answer: B

Although acetazolamide alkalinizes the urine, it simultaneously lowers the systemic pH, which defeats the purpose and may harm the patient.

Urinary alkalinization is a primary mode of treatment in many drug overdoses. All drugs that meet the following criteria can be treated with urinary alkalinization:
  • predominantly eliminated unchanged by the kidney
  • distributed primarily in the extracellular fluid compartment (low volume of distribution)
  • minimally protein-bound
  • weak acids with pKa ranging from 3.0 to 7.5
The most common are: Salicylates, Methotrexate, Barbiturates, Phenobarbital, Primidone and Sulfonamides

Using sodium bicarbonate to achieve a urine pH of 7.5 or higher while maintaining a serum pH no higher than 7.55 to 7.6 is the primary way to alkalinize urine. Unfortunately, kidney failure, pulmonary edema (volume overload), and/or cerebral edema, and severe concomitant hypokalemia are some of the contraindications for its use.

Sodium acetate as a replacement for sodium bicarbonate has been used in some cases where it is not available, though it can be given only as an infusion without a bolus (reference # 3).


#toxicology
#acid-base


References:

1. Proudfoot AT, Krenzelok EP, Vale JA. Position Paper on urine alkalinization. J Toxicol Clin Toxicol 2004; 42:1.

2. Garrettson LK, Geller RJ. Acid and alkaline diuresis. When are they of value in the treatment of poisoning? Drug Saf 1990; 5:220.

3. Neavyn MJ, Boyer EW, Bird SB, Babu KM. Sodium acetate as a replacement for sodium bicarbonate in medical toxicology: a review. J Med Toxicol 2013; 9:250.

Saturday, November 7, 2026

2 major types of Hanta virus

Q: Which of the following is NOT described (yet) as one of the two Hantavirus severe acute febrile illnesses? - select one

A) Hantavirus cardiopulmonary syndrome 
B) Hemorrhagic fever with hepatic syndrome
C) Hemorrhagic fever with renal syndrome 


Answer: B

So far, Hantaviruses are clinically associated with two severe acute febrile illnesses.
  • Hemorrhagic fever with renal syndrome (HFRS) 
  • Hantavirus cardiopulmonary syndrome (HCPS)
HFRS is mostly reported in Korean (Asian) people and, as the name implies, has two components and five phases. It primarily damages small blood vessels and leads to acute kidney injury (AKI). The five phases are: febrile, hypotensive, oliguric, diuretic, and convalescent.

HCPS is reported mostly in the SW USA area (though it can occur anywhere). It has three phases: prodromal, cardiopulmonary, and recovery. With ongoing wide availability of ECMO in the USA, there is hope that, once expected to be a very high-mortality disease, it will offer good recovery despite more and more cases being reported.


#ID



References:


1. Tariq M, Kim DM. Hemorrhagic Fever with Renal Syndrome: Literature Review, Epidemiology, Clinical Picture and Pathogenesis. Infect Chemother. 2022 Mar;54(1):1-19. doi: 10.3947/ic.2021.0148. PMID: 35384417; PMCID: PMC8987181.

2. Ulloa-Morrison R, Pavez N, Parra E, Lopez R, Mondaca R, Fernandez P, Kraunik D, Sanhueza C, Bravo S, Cornu MG, Kattan E. Critical care management of hantavirus cardiopulmonary syndrome. A narrative review. J Crit Care. 2024 Dec;84:154867. doi: 10.1016/j.jcrc.2024.154867. Epub 2024 Jul 17. PMID: 39024823.

3. Rao A, Tariq H. Hantavirus cardiopulmonary syndrome: an emerging fatal zoonotic infection. Infection. 2026 Oct 3. doi: 10.1007/s15010-026-02994-6. Epub ahead of print. PMID: 42828628.

Friday, November 6, 2026

PCC and aPCC

Q: Activation of which blood coagulation factor converts Unactivated prothrombin complex concentrate (PCC) to activated PCC (aPCC)? - select one

A) factor II
B) factor VII
C) factor IX
d) factor X
E) Protein C


Answer: B

At the definition level: 

- Unactivated PCC contains vitamin K-dependent coagulation factors, which can be either 3-factor (factors II, IX, X) or 4-factor (factors II, VII, IX, X). The factors are all inactive.

- Activated aPCC also contains inactive factors II, IX, and X, variable inactive factor VII, BUT a significant portion of activated factor VII (factor VIIa). It also contains small amounts of some other activation products.

Thrombotic risks have always been a concern with both PCC and aPCC administration.


#hematology


References:

1. van den Brink DP, Wirtz MR, Neto AS, Schöchl H, Viersen V, Binnekade J, Juffermans NP. Effectiveness of prothrombin complex concentrate for the treatment of bleeding: A systematic review and meta-analysis. J Thromb Haemost. 2020 Oct;18(10):2457-2467. doi: 10.1111/jth.14991. Epub 2020 Aug 2. PMID: 32638483; PMCID: PMC7589201.

2. Sheikh-Taha M, Crawley RM. Efficacy and safety of activated prothrombin complex concentrate for the reversal of vitamin K antagonist major bleeding. Sci Rep. 2022 Feb 2;12(1):1814. doi: 10.1038/s41598-022-05803-w. PMID: 35110612; PMCID: PMC8810750.

3. Crawley RM, Sheikh-Taha M. Comparison of activated and 4-factor prothrombin complex concentrates for reversal of apixaban- and rivaroxaban-associated major bleeding. J Thromb Thrombolysis. 2026 Mar;59(3):610-615. doi: 10.1007/s11239-025-03232-w. Epub 2026 Jan 12. PMID: 41525014.

Thursday, November 5, 2026

Intestinal ischemia after abdominal aortic surgery

Q: 52 years old male is admitted to the ICU after abdominal aortic dissection repair. 24 hours post-surgery, the patient complains of acute abdominal pain. CTA of the abdomen is consistent with acute colonic ischemia. Which side of the colon is probably affected?

A) Left
B) Right


Answer: A

With open aortic surgery, colonic ischemia almost always affects the distal left colon. Some of the surgical causes are:
  • loss of collateral flow due to inferior mesenteric artery ligation
  • iliac artery ligation
  • embolic events
  • vascular compression with surgical instruments
  • hypotension leading to hypoperfusion
On a similar note, some cardiac interventions, such as cardiac catheterization or valve implantation, can also cause colonic ischemia.


#surgical-critical-care
#GI


References:

1. Abromaitis D, Antusevas A. Zarnyno isemijos prevencija po pilvo aortos rekonstrukciniu operaciju [Prevention of intestinal ischemia after abdominal aortic reconstructive surgery]. Medicina (Kaunas). 2005;41(4):295-304. Lithuanian. PMID: 15864002.

2. Ding P, Zhou Y, Long KL, Zhang S, Gao PY. Acute mesenteric ischemia due to percutaneous coronary intervention: A case report. World J Clin Cases. 2022 Oct 6;10(28):10244-10251. doi: 10.12998/wjcc.v10.i28.10244. PMID: 36246830; PMCID: PMC9561597.

3. Michalopoulos GC, Bikeyeva V, Paolella G, Adams J, Labchuk A, Chaus A. Non-occlusive Mesenteric Ischemia Following Transcatheter Aortic Valve Replacement: A Case Report. Cureus. 2025 Jul 7;17(7):e87468. doi: 10.7759/cureus.87468. PMID: 40630765; PMCID: PMC12237081.

Wednesday, November 4, 2026

FIB-4 Index

<1 .3="" advanced="" and="" cirrhosis="" fibrosis="" indeterminate="" less="" likely="">
Q: Which of the following is NOT part of the Fibrosis-4 (FIB-4) Index in liver diseases?

A) Age 
B) ALT
C) AST
D) Bilirubin
E) Platelets


Answer: D

MASLD was previously known as nonalcoholic fatty liver disease (NAFLD). The FIB-4 score is used to assess fibrosis and cirrhosis. It applies to patients aged 35 and older. It is based on the formula:

FIB-4 = Age * AST / (0.001 * Platelets * sqr(ALT)) 
The formula uses US units.

Cutoff values for suspecting liver fibrosis vary by study and by the etiology of liver disease. The FIB-4 index Risk:
  • <1.3  = Advanced fibrosis/cirrhosis less likely
  • ≥1.3 and ≤2.67  = Indeterminate
  • >2.67   = Advanced fibrosis/cirrhosis more likely
  
FIB-4 index is found to have a good predictive accuracy for advanced fibrosis, particularly in patients with chronic Hepatitis C (HCV) and in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), which was previously known as nonalcoholic fatty liver disease (NAFLD), where the area under the ROC curve for predicting adverse liver-related outcomes was 0.81 and for predicting death or liver transplantation was 0.67.
  
FIB-4 values have also been associated with the risk of developing hepatocellular carcinoma (HCC) in alcoholic patients, where it is used in correlation with the level of alcohol consumption.
  

#hepatology
  
  

References:
  
 1. Angulo P, Bugianesi E, Bjornsson ES, et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2013; 145:782.
  
 2. Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007; 46:32.
  
 3. Suh B, Yun JM, Park S, et al. Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index. Cancer 2015; 121:3818.
  
 4. Sterling RK, Patel K, Duarte-Rojo A, et al. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology 2025; 81:321.

Tuesday, November 3, 2026

transfusions in kidney transplant patients

Q: All post-kidney transplant patients should receive irradiated blood if transfusion is required.

A) Yes
B) No


Answer: B

Ideally, all blood transfusions should be avoided in any awaiting or solid organ transplant patients as far as possible to minimize the risk of allosensitization and rejection. If transfusion becomes necessary, order cytomegalovirus (CMV)-seronegative and/or filtered blood products instead of only leukocyte-reduced products, as CMV infection may occur even with only leukoreduced blood transfusion (reference #1). 

Blood product irradiation is not required.


#transfusion
#transplantation


References:

1. Obrador GT, Macdougall IC. Effect of red cell transfusions on future kidney transplantation. Clin J Am Soc Nephrol 2013; 8:852.

2. Nichols WG, Price TH, Gooley T, et al. Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 2003; 101:4195.

3. Triulzi DJ. Specialized transfusion support for solid organ transplantation. Curr Opin Hematol 2002; 9:527.

Monday, November 2, 2026

Pseudo-Cushing

Q: Patients with physiologic hypercortisolism are more prone to have proximal muscle atrophy and weakness.

A) True 
B) False


Answer: B

When hypercortisolism occurs in any disorder other than Cushing syndrome, it is called physiologic or pseudo-Cushing syndrome. These patients usually are spared of some cardinal signs of true Cushing syndrome, such as easy bruising, thinning, friability) or proximal muscle atrophy and weakness.

Some well-known conditions/disorders causing physiologic hypercortisolism and Cushing syndrome are:
  • Pregnancy
  • Severe obesity
  • Polycystic ovary syndrome (PCOS)
  • Psychological stress
  • Poorly controlled diabetes mellitus
  • Chronic alcoholism, particularly during withdrawal
  • Severe illness
  • Obstructive sleep apnea
  • Intense chronic exercise
  • Hypothalamic amenorrhea

#endocrinology


References:

1. Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003; 88:5593.

2. Chabre O. The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism"). Ann Endocrinol (Paris). 2018 Jun;79(3):138-145. doi: 10.1016/j.ando.2018.04.017. Epub 2018 Apr 30. PMID: 29716734.

3. Pecori Giraldi F, Ambrogio AG. Pseudo-Cushing - A Clinical Challenge? Front Horm Res. 2016;46:1-14. doi: 10.1159/000443859. Epub 2016 May 17. PMID: 27211794.

Sunday, November 1, 2026

humidification of inspired gas

Q: What are the few advantages of humidifying the oxygen via High Flow Nasal Cannula (HFNC)?


Answer: It is standard practice to warm and humidify inspired oxygen to body temperature, especially when delivering high-flow oxygen, typically above 40 L/minute. This increased humidification serves three main purposes:
  • increased water content in mucus, which facilitates secretion removal
  • decreases the work of breathing (WOB), and 
  • avoids airway desiccation and so prevents epithelial injury 

#respiratory


References:

1. Williams R, Rankin N, Smith T, et al. Relationship between the humidity and temperature of inspired gas and the function of the airway mucosa. Crit Care Med 1996; 24:1920.

2. Hasani A, Chapman TH, McCool D, et al. Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chron Respir Dis 2008; 5:81.